Robustness tests on the United States Pharmacopoeia XXVI HPLC assay for ginsenosides in Asian and American ginseng using an experimental design

Analytica Chimica Acta

Volumn 536, Issue 1-2, 2005, Pages 29-38

  Li, Yong Guo ^a,b   Liu, Hong ^c   Heyden, Y Vander ^d   Chen, Ming ^a,b   Wang, Zheng Tao ^a,b   Hu, Zhi Bi ^a,b  

^a Shanghai RandD Ctr S   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^d VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

American ginseng; Asian ginseng; Fractional factorial design; Ginsenosides; Robustness test; System suitability parameters

Indexed keywords

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LABORATORIES; RECOVERY; RHENIUM; RUBIDIUM;

GINSENOSIDES; PHYTOMEDICINES; RELATIVE RETENTION TIME (RRT);

BIOASSAY;

GINSENOSIDE; GINSENOSIDE RB 1; GINSENOSIDE RC; GINSENOSIDE RD; GINSENOSIDE RE; GINSENOSIDE RG 1; GINSENOSIDE RG 2; UNCLASSIFIED DRUG;

ARTICLE; ASIA; CALCULATION; GINSENG; GINSENOSIDE RF; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEASUREMENT; MEDICAL LITERATURE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; UNITED STATES; VALIDATION PROCESS;

EID: 17144384735     PISSN: 00032670     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aca.2004.12.071     Document Type: Article

References (19)

1. D.Q. Dou, L. Jin, and Y.J. Chen J. Shenyang Pharm. Univ. 16 1999 151
2. C.I. Coleman, J.H. Hebert, and P. Reddy J. Clin. Pharm. Ther. 28 2003 5
3. W.F. Bao, H.B. Li, and B.Y. Yang J. Shenyang Pharm. Univ. 15 1998 149
4. Q.C. Ji, M.R. Harkey, and G.L. Henderson Phytochem. Anal. 12 2001 320
5. W.K. Li, Ch.G. Gu, H.J. Zhang, D.V.C. Awang, J.F. Fitzioff, H.H.S. Fong, and R.B.V. Breemen Anal. Chem. 72 2000 5417
6. The United States Pharmacopoeia XXIV (USP24), The National Formulary 19 (NF19), United States Pharmacopoeia Convention. Rockville, MD, 1999, p. 2460.
7. The United States Pharmacopoeia XXVI (USP26), The National Formulary 21 (NF21), United States Pharmacopeial Convention. Rockville, MD, 2002, p. 2758.
8. The United States Pharmacopoeia XXVII (UPS27), The National Formulary 21 (NF22), United States Pharmacopeial Convention. Rockville, MD, 2003, p. 2007.
9. Renshen (RADIX GINSENG), China Pharmacopoeia 2000, Beijing, 1995, p. 6.
10. Xiyangshen (RADIX PANACIS QUINQUEFOLII), China Pharmacopoeia 2000, Beijing, 1995, p. 99.
11. Y.G. Li, M. Chen, G.X. Chou, and Zh.T. Wang J. Pharm. Biomed. Anal. 35 2004 1083
12. The International Conference on Harmonisation (ICH), Harmonised Tripartite Guideline Prepared Within the Third International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use, Q2A, Validation of Analytical Methods, 1996.
13. A. Nijhuis, H.C.M. van der Knaap, S. de Jong, and B.G.M. Vandeginste Anal. Chim. Acta 391 1999 187
14. Y. Vander Heyden, A. Nijhuis, J. Smeyers-Verbeke, B.G.M. Vandeginste, and D.L. Massart J. Pharm. Biomed. Anal. 24 2001 723
15. Y. Vander Heyden, D.L. Massart, Y. Zhu, J. Hoogmartens, and J. De Beer J. Pharm. Biomed. Anal. 14 1996 1313
16. Y. Vander Heyden, F. Questier, and D.L. Massart J. Pharm. Biomed. Anal. 17 1998 153
17. E. Hund, Y. Vander Heyden, D.L. Massart, and J. Smeyers-Verbeke J. Pharm. Biomed. Anal. 30 2002 1197
18. C.P. Xu, S.W. Kim, H.J. Hwang, and J.W. Yun Biotechnol. Appl. Biochem. 36 2002 127
19. F. Dong Statist. Sinica 3 1993 209